CN1252300A - Compounding method of carcinomatosis resisting medicine - Google Patents
Compounding method of carcinomatosis resisting medicine Download PDFInfo
- Publication number
- CN1252300A CN1252300A CN 99115193 CN99115193A CN1252300A CN 1252300 A CN1252300 A CN 1252300A CN 99115193 CN99115193 CN 99115193 CN 99115193 A CN99115193 A CN 99115193A CN 1252300 A CN1252300 A CN 1252300A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- carcinomatosis
- resisting medicine
- compound method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A carcinomatosis-resisting medicine is compounded with Codonopsis Pilosulae, Atractylodis Macrocephalae, tuckahoe and licorice. To the said basic ingredients, other tens of Chinese medicinal materials including Astragalus hoongtchy, Chinese angelica, Hedyotis Diffusae, etc. may be added to constitute serial cacinomatosis-resisting medicine products for the need of different disease states. It is preferable to take the medicine along with glossy ganoderma for curing the disease radically and fast convalescence.
Description
The present invention relates to a kind of compound method of Chinese medicine, be specifically related to a kind of compound method of carcinomatosis resisting medicine.
Ganoderma has the effect of kill cancer cell and life lengthening, and the market ganoderma lucidum product has multiple.But cancer patient is physical weakness often, and has multiple symptom, must adopt Ganoderma to cooperate with the reasonable of other drug, ability treating both the principal and secondary aspects of a disease, speedy recovery to health.
Purpose of the present invention overcomes the prior art defective exactly, seeks a kind of compound method of the serial carcinomatosis resisting medicine that is used according to patient's needs and Ganoderma.
The objective of the invention is to adopt following proposal to realize.
Prescription of the present invention is Radix Codonopsis 10-20 part (weight), Rhizoma Atractylodis Macrocephalae 12-18 part, Poria 15-25 part, Radix Glycyrrhizae 3-6 part.
Also can add Radix Astragali 12-20 part in the such scheme, Radix Angelicae Sinensis 9-12 part, Fructus Lycii 16-25 part.
Also can add Herba Hedyotidis Diffusae 30-45 part in the such scheme, Herba Scutellariae Barbatae 15-30 part, Radix Sophorae Tonkinensis 10-15 part, Radix Sophorae Flavescentis 6-9 part.
Also can add Fructus Ligustri Lucidi 9-14 part in the such scheme, Herba Ecliptae 10-15 part, Radix Rehmanniae Preparata 12-15 part, Radix Curcumae 10-12 part, Fructus Aurantii Immaturus 6-10 part.
Also can add rhizoma sparganic 10-12 part in the such scheme, Rhizoma Curcumae 9-13 part, Radix Scrophulariae 10-12 part, Concha Ostreae 20-30 part.
The effect of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria is a replenishing QI to invigorate the spleen in the such scheme: the effect of the Radix Astragali, Radix Angelicae Sinensis, Fructus Lycii is an invigorating qi and benefiting blood; The effect of Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Radix Sophorae Tonkinensis, Radix Sophorae Flavescentis is a heat-clearing and toxic substances removing; The effect of Fructus Ligustri Lucidi, Herba Ecliptae, Radix Rehmanniae Preparata, Radix Curcumae, Fructus Aurantii Immaturus is to reverse differentiation, and YIN nourishing is regulated the flow of vital energy, and impels the cancerous cell differentiation; The effect of rhizoma sparganic, Rhizoma Curcumae, Radix Scrophulariae, Concha Ostreae is that the gram cancer disappears bitterly, and hard masses softening and resolving kills anticancer.
Product of the present invention, can be used (the Ganoderma consumption does not have strict restriction) with Ganoderma according to the needs of the different state of an illness.
The compound method of Chinese medicine of the present invention, the single medicinal material granule that can adopt prior art to make is taken by above-mentioned formula combination, also above-mentioned Chinese medicine can be made powder, takes after becoming product by above-mentioned formulated.The single current system journey is 20 days, can use continuously the 3-5 course of treatment.
Can obtain series of products behind product that the method for the invention makes and the Ganoderma prescription, and the effect of anticancer transfer is arranged, can select for use different patients, make anticancer effect more remarkable, patient's body constitution is more strong, can play the inaccessible effect of single clothes Ganoderma medicine.
Be embodiments of the invention below.
Embodiment 1
With 15 parts of Radix Codonopsis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 5 parts of single medicinal materials of Radix Glycyrrhizae mix or pulverize, cross 20 mesh sieves separately, through water boil 45 minutes, filter, and obtain extracting solution.To permeate not, aforesaid operations secondary repeatedly obtains extracting solution again, and extracting solution concentrates through cryogenic vacuum, moment spray drying, granulate again and be packaged into product or single medicinal material decoction pieces concentrated granular.For single medicinal material bamboo chip concentrated granular, by the prescription combination, directly take after mixing it with water when taking.
Embodiment 2
With 10 parts of Radix Codonopsis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 3 parts in Radix Glycyrrhizae, 15 parts of the Radixs Astragali, 10 parts of Radix Angelicae Sinensis, are crossed 20 mesh sieves at 20 parts of pulverizing of Fructus Lycii, through water boil 1 hour, filter, and obtain extracting solution.To permeate not, aforesaid operations secondary repeatedly obtains extracting solution again, and extracting solution concentrates through cryogenic vacuum, moment spray drying, granulate again pack product.
Embodiment 3
With 12 parts of Radix Codonopsis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts in Poria, 3 parts in Radix Glycyrrhizae, 35 parts of Herba Hedyotidis Diffusaes, 20 parts of Herba Scutellariae Barbataes, 12 parts of Radix Sophorae Tonkinensiss, sieve at 8 parts of pulverizing of Radix Sophorae Flavescentis, through water boil 1 hour, filter, and obtain extracting solution.To permeate not, aforesaid operations secondary repeatedly obtains extracting solution again, and extracting solution concentrates through cryogenic vacuum, moment spray drying, the packing of granulating again, product, directly take and get final product.
Embodiment 4
With 15 parts of Radix Codonopsis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts in Poria, 3 parts in Radix Glycyrrhizae, 12 parts of Fructus Ligustri Lucidi, 12 parts of Herba Ecliptaes, 15 parts in Radix Rehmanniae Preparata, 10 parts of Radix Curcumaes, 9 parts of Fructus Aurantii Immaturuss, the preparation method of pressing embodiment one or embodiment two obtains product.
Embodiment 5
With 10 parts of Radix Codonopsis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts in Poria, 4 parts in Radix Glycyrrhizae, 11 parts of rhizoma sparganic, 12 parts of Rhizoma Curcumae, 10 parts of Radix Scrophulariaes, 25 parts of Concha Ostreaes, the method for pressing embodiment one or embodiment two obtains product.
Claims (5)
1. the compound method of carcinomatosis resisting medicine is characterized in that being made up of for 3～6 parts Radix Codonopsis 10～12 parts of (weight), 12～18 parts of the Rhizoma Atractylodis Macrocephalaes, 15～25 parts in Poria, Radix Glycyrrhizaes.
2. the compound method of carcinomatosis resisting medicine according to claim 1 is characterized in that adding 12～20 parts of the Radixs Astragali, 9～12 parts of Radix Angelicae Sinensis, 16～25 parts of compositions of Fructus Lycii.
3. the compound method of carcinomatosis resisting medicine according to claim 1 and 2 is characterized in that adding 30～45 parts of Herba Hedyotidis Diffusaes, 15～30 parts of Herba Scutellariae Barbataes, 10～15 parts of Radix Sophorae Tonkinensiss, 6～9 parts of Radix Sophorae Flavescentiss.
4. the compound method of carcinomatosis resisting medicine according to claim 1 is characterized in that adding 9～14 parts of Fructus Ligustri Lucidi, 10～15 parts of Herba Ecliptaes, 12～15 parts in Radix Rehmanniae Preparata, 10～12 parts of Radix Curcumaes, 6～10 parts of Fructus Aurantii Immaturuss.
5. the compound method of carcinomatosis resisting medicine according to claim 1 is characterized in that adding 10～12 parts of rhizoma sparganic, 9～13 parts of Rhizoma Curcumae, 10～12 parts of Radix Scrophulariaes, 20～30 parts of Concha Ostreaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99115193 CN1252300A (en) | 1999-10-10 | 1999-10-10 | Compounding method of carcinomatosis resisting medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99115193 CN1252300A (en) | 1999-10-10 | 1999-10-10 | Compounding method of carcinomatosis resisting medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1252300A true CN1252300A (en) | 2000-05-10 |
Family
ID=5278199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99115193 Pending CN1252300A (en) | 1999-10-10 | 1999-10-10 | Compounding method of carcinomatosis resisting medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1252300A (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169781A (en) * | 2013-03-12 | 2013-06-26 | 翁捷 | Pharmaceutical composition for treating brain tumor |
| CN103169919A (en) * | 2013-03-12 | 2013-06-26 | 张成全 | Pharmaceutical composition for treating brain tumor and preparation method thereof |
| CN103230468A (en) * | 2013-04-28 | 2013-08-07 | 苏州谷力生物科技有限公司 | Traditional Chinese medicine composition with functions of tonifying spleens and nourishing stomachs and preparation method thereof |
| CN104013709A (en) * | 2014-06-25 | 2014-09-03 | 王在峰 | Oral cancer-resistance and body resistance-strengthening decoction |
| CN104127572A (en) * | 2014-07-31 | 2014-11-05 | 河南科技大学第一附属医院 | Preparation method for traditional Chinese medicine composition for treating lung cancer |
| CN104435484A (en) * | 2014-11-19 | 2015-03-25 | 上海市闸北区临汾路街道社区卫生服务中心 | Seven connected traditional Chinese medicine packets for treating colorectal cancer |
| CN106266765A (en) * | 2016-08-31 | 2017-01-04 | 郑心 | A kind of anti-lung-cancer medicament being applicable to phlegm-damp matter and preparation method thereof |
| CN107261072A (en) * | 2017-07-15 | 2017-10-20 | 杨桂森 | A kind of Chinese medicine for curing cancer after ocal resection and/or chemotherapy |
| CN110101825A (en) * | 2019-06-25 | 2019-08-09 | 张家港市力锦源科技发展有限公司 | A kind of Chinese medicine for the treatment of cancer |
| CN112569307A (en) * | 2020-11-17 | 2021-03-30 | 广州中医药大学第一附属医院 | Traditional Chinese medicine composition for strengthening body resistance and eliminating tumor as well as preparation method and application thereof |
| CN113274447A (en) * | 2021-06-10 | 2021-08-20 | 衢州市王德裕堂国药有限公司 | Anti-tumor traditional Chinese medicine composition |
| CN113274426A (en) * | 2021-07-12 | 2021-08-20 | 南阳理工学院 | Formula and preparation process of cassia twig and poria cocos pills for inhibiting tumor metastasis |
-
1999
- 1999-10-10 CN CN 99115193 patent/CN1252300A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169781B (en) * | 2013-03-12 | 2015-07-22 | 翁捷 | Pharmaceutical composition for treating brain tumor |
| CN103169919A (en) * | 2013-03-12 | 2013-06-26 | 张成全 | Pharmaceutical composition for treating brain tumor and preparation method thereof |
| CN103169781A (en) * | 2013-03-12 | 2013-06-26 | 翁捷 | Pharmaceutical composition for treating brain tumor |
| CN103230468A (en) * | 2013-04-28 | 2013-08-07 | 苏州谷力生物科技有限公司 | Traditional Chinese medicine composition with functions of tonifying spleens and nourishing stomachs and preparation method thereof |
| CN104013709A (en) * | 2014-06-25 | 2014-09-03 | 王在峰 | Oral cancer-resistance and body resistance-strengthening decoction |
| CN104127572A (en) * | 2014-07-31 | 2014-11-05 | 河南科技大学第一附属医院 | Preparation method for traditional Chinese medicine composition for treating lung cancer |
| CN104435484A (en) * | 2014-11-19 | 2015-03-25 | 上海市闸北区临汾路街道社区卫生服务中心 | Seven connected traditional Chinese medicine packets for treating colorectal cancer |
| CN106266765A (en) * | 2016-08-31 | 2017-01-04 | 郑心 | A kind of anti-lung-cancer medicament being applicable to phlegm-damp matter and preparation method thereof |
| CN107261072A (en) * | 2017-07-15 | 2017-10-20 | 杨桂森 | A kind of Chinese medicine for curing cancer after ocal resection and/or chemotherapy |
| CN110101825A (en) * | 2019-06-25 | 2019-08-09 | 张家港市力锦源科技发展有限公司 | A kind of Chinese medicine for the treatment of cancer |
| CN112569307A (en) * | 2020-11-17 | 2021-03-30 | 广州中医药大学第一附属医院 | Traditional Chinese medicine composition for strengthening body resistance and eliminating tumor as well as preparation method and application thereof |
| CN112569307B (en) * | 2020-11-17 | 2021-12-14 | 广州中医药大学第一附属医院 | Traditional Chinese medicine composition for strengthening body resistance and eliminating tumor as well as preparation method and application thereof |
| CN113274447A (en) * | 2021-06-10 | 2021-08-20 | 衢州市王德裕堂国药有限公司 | Anti-tumor traditional Chinese medicine composition |
| CN113274426A (en) * | 2021-07-12 | 2021-08-20 | 南阳理工学院 | Formula and preparation process of cassia twig and poria cocos pills for inhibiting tumor metastasis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1114435C (en) | Ganlu pill and its preparing process | |
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1686529A (en) | Ready prepared Chinese medicine for treating diabetes | |
| CN1319414A (en) | Medicine for treating hecrosis of femoral head | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN1302645A (en) | Medical capsule for invigorating function of spleen and its preparing process | |
| CN1252300A (en) | Compounding method of carcinomatosis resisting medicine | |
| CN1203871C (en) | Medicine for treating diseases of digestive system | |
| CN1027622C (en) | A tonic and health protecting preparation | |
| CN1899529A (en) | Chinese medicine for treating chronic virus hepatitis B and its producing method | |
| CN1159037C (en) | Medicine for treating apoplexy | |
| CN1903321A (en) | Traditional Chinese medicine pills for prolonging life and consolidating vital essential | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN1160560A (en) | Chinese patent drug for curing leukopenia and its preparation process | |
| CN1242775C (en) | Bushenshansong drink and preparation method thereof | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN1285378C (en) | Nourishing wine for regulating human body balance function | |
| CN101455819B (en) | Nutrient health product for treating chronic hepatitis B | |
| CN1217204A (en) | Medicine for nourishing muscle and recovering physical strength, and preparation method therefor | |
| CN102488851B (en) | Drug for treating recurrent genital herpes and preparation method thereof | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1814153A (en) | Medicine composition for preventing and treating breast cancer and preparing method | |
| CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
| CN1201799C (en) | Chinese medicine preparation for curing osteoporosis and preparing method thereof | |
| CN1259363A (en) | Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Huang Xiaowei Document name: Deemed as a notice of withdrawal |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |